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Graphical abstract 
We obtained an ideal correlation between the permeability coefficients across the 
poly(dimethylsiloxane)/poly(ethylene glycol) 6000 (PDMS/PEG 6000) copolymer by 
using a 96-well plate and those obtained across the human skin. 
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ABSTRACT  
We aimed to develop a high-throughput screening (HTS) system for preliminary 
predictions of human skin permeability by using an artificial membrane that can mimic 
the permeation behaviour of lipophilic and hydrophilic compounds across the human skin. 
In this study, we synthesized a copolymer containing poly(dimethylsiloxane) (PDMS) 
and poly(ethylene glycol) (PEG) 6000 and impregnated it onto a supportive membrane 
filter to prepare a PDMS/PEG 6000 copolymer-impregnated membrane. In addition, we 
synthesized another polymer without PEG units and used it to prepare an impregnated 
membrane for determining the role of PEG 6000 units in the PDMS/PEG 6000 
copolymer-impregnated membrane. The permeation characteristics of the impregnated 
membranes were evaluated on the basis of the permeability coefficients of 12 model 
compounds with different lipophilicities, by using a 2-chamber diffusion cell, and these 
permeability coefficients were compared with those across the human skin. We obtained a 
good correlation between the permeability coefficients across the PDMS/PEG 6000 
copolymer-impregnated membrane and human skin. Further, we evaluated the 
permeation characteristics of a 96-well plate model of the PDMS/PEG 6000 copolymer 
by using 6 model compounds. We obtained an ideal correlation between the permeability 
coefficients across the PDMS/PEG 6000 copolymer using a 96-well plate and those 
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across the human skin. Thus, the PDMS/PEG 6000 copolymer would be a good candidate 
for preliminary evaluation of the permeability of lipophilic and hydrophilic compounds 
across the human skin. 
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1. Introduction  
 
Estimation of the skin permeability of various compounds is important for 
determining the potential of transdermal application of pharmaceutical and cosmetic 
products and for assessing the risk of toxic chemicals. Preliminary evaluations of the 
permeability of a large number of compounds and their formulations by in vivo and in 
vitro studies using human or animal skin are not feasible. Thus, a high-throughput 
screening (HTS) system is a desirable method for these studies.  
The parallel artificial membrane permeation assay (PAMPA) was developed as a 
HTS system for estimation of passive membrane permeability of molecules, and the 
PAMPA model has been used mainly to predict the gastrointestinal absorption (Avdeef et 
al., 2007; Kansy et al., 1998; Sugano et al., 2003). However, few studies have reported the 
use of the PAMPA for determining the skin permeability (Ottaviani et al., 2006; Sinkó et 
al., 2012). The ability of several synthetic membranes to predict skin permeability has 
been studied by using a 2-chamber diffusion cell (Dias et al., 2007; Geinoz et al., 2002; 
Hatanaka et al., 1992; Wasdo et al., 2009). While these membranes could be used to 
predict the skin permeability of lipophilic compounds, they could not be used for 
hydrophilic compounds; moreover, fewer studies have been performed using these 
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membranes in hydrophilic compounds than in lipophilic compounds. 
Typically, the permeability of the skin is lower for hydrophilic compounds than for 
lipophilic compounds because the stratum corneum (SC) is a highly lipophilic barrier. 
Evaluation of the permeability of the skin for both lipophilic and hydrophilic compounds 
is required, and an artificial membrane is required to perform these preliminary 
evaluations. 
In a previous study, we synthesized copolymers using the lipophilic materials, 
methyl methacrylate (MMA) and glycidyl methacrylate (GMA), and the hydrophilic 
macro-azo-initiator poly(polyoxyethylene-azobiscyanopentanoate) (VPE-0601), which 
had poly(ethylene glycol) (PEG) 6000 units with an average molecular weight (MW) of 
approximately 6000 Da (Miki et al., 2010). We identified the possibility that the PEG 
6000 units formed a hydrophilic microdomain in the copolymer membranes.  
Silicone, poly(dimethylsiloxane) (PDMS), is a popular rubbery polymer component; 
it is stable, inert, and used for the dissolution of chemicals (De Coensel et al., 2007). The 
permeability of hydrophilic compounds across PDMS membranes has often been 
undetectable because of the highly lipophilic nature and non-aqueous pore structure of 
these membranes. 
Our aim is to develop a HTS system for predicting the permeability of the human 
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skin using an artificial membrane that could mimic the permeation behaviour of 
lipophilic and hydrophilic compounds across the human skin. In this study, we 
synthesized a copolymer with PDMS and PEG 6000 units. To enable comparison with a 
polymer containing PEG 6000 units, we also synthesized a polymer without PEG 6000 
units. We evaluated the average MW and composition of the synthetic polymers by using 
gel permeation chromatography (GPC) and proton nuclear magnetic resonance 
(1H-NMR). The synthesized polymers were viscous liquids, and thus, membranes 
impregnated with these polymers could be prepared easily using a membrane filter and 
could be used in a PAMPA model with a 96-well plate. We evaluated the permeation 
behaviours of model compounds with different lipophilicities through the impregnated 
membranes containing the polymers with or without PEG units (Table 1) by using a 
2-chamber diffusion cell, and we compared them with those through the human skin 
(Morimoto et al., 1992). Further, we evaluated the permeation behaviours using the 
PAMPA model with the synthesized polymer.  
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2. Materials and methods 
 
2.1. Materials  
VPE-0601, 2,2′-azobis(2-methylbutyronitrile) (AMBN), aminopyrine (AMP), 
antipyrine (ANP), ketoprofen (KP), and PEG 400 were obtained from Wako Pure 
Chemical Industrial Co. (Osaka, Japan). Cyclobarbital (CB), diclofenac sodium (DC-Na), 
isoproterenol hydrochloride (IPH), and lidocaine (LC) were purchased from Tokyo Kasei 
Kogyo Co. (Tokyo, Japan). Dopamine hydrochloride (DPH) was purchased from 
Yodogawa Pharmaceutical Industries Co. (Osaka, Japan). Isosorbide dinitrate (ISDN) 
and flurbiprofen (FP) were kindly supplied by Toko Pharmaceutical Industries Co. 
(Tokyo, Japan). L-dihydroxyphenylalanine (L-dopa; L-DP) was obtained from 
Sigma–Aldrich Japan (Tokyo, Japan). Nicorandil (NR) was obtained from Nisshin Flour 
Milling Co. (Tokyo, Japan). α-Butyl-ω-(3-methacryloxypropyl)polydimethylsiloxane 
(SILAPLANE; FM-0711), with PDMS units of an average MW of 724 Da, was 
generously provided by JNC Co. (Tokyo, Japan). All other chemicals and solvents were 
of reagent grade and were obtained commercially. VPE-0601 was refined by 
recrystallization in chloroform, as the good solvent, and hexane, as the poor solvent (Miki 
et al., 2010). All of the above chemicals, except VPE-0601, were used without further 
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purification. We used 12 compounds (Morimoto et al., 1992) as penetrants in the 
permeation study performed using a 2-chamber diffusion cell for each impregnated 
membrane (Tables 1-2). We used six compounds (KP, LC, ISDN, AMP, DC-Na and NR) 
as penetrants for the PAMPA experiments (Morimoto et al., 1992).  
 
2.2. Synthesis of polymers 
For the initiation of the radical polymerization reaction, specified amounts of 
purified VPE-0601 or AMBN and FM-0711, weighing a total of 9.0 g, were placed into 
a glass tube with 30 ml of chloroform to synthesize polymers A and B (Fig. 1 and Table 
3). The tube was sealed using a 3-way cock and was freeze-thawed to remove the 
oxygen. The tube was kept at 65°C in a water bath for 24 h to allow the reaction to take 
place. After dismounting the 3-way cock, the tube was kept at 65°C for an additional 24 
h to allow the solvent to evaporate. The reaction mixture and 20 ml of the poor solvent 
were blended and were stirred for 1 h to refine the hydrophilic low-MW polymer and the 
unreacted initiator from the mixture. A mixture of methanol and water (70:30) was used 
as the poor solvent for polymer A, and ethanol was used for polymer B. After stirring, 
the blended liquid was kept still at room temperature for 1 h for it to separate into two 
phases; the upper phase then was removed using a Pasteur pipette. In addition, for 
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polymer B, a mixture of ethanol and chloroform (80:20) was used as a second poor 
solvent to remove any unreacted FM-0711, and the same procedure was performed for 
refinement. Then, the lower phases in the reaction mixture were dried at 100°C for 48 h 
in an oven to remove any remaining solvent. 
 
2.3. Evaluation of synthetic polymers 
 
2.3.1. Estimation of the average MW 
GPC was used to determine the number-average MW (Mn), the weight-average MW 
(Mw), and the polydispersity (Mw/Mn) of the polymers. GPC was performed using a 
column (K-804L; Showa Denko, Tokyo, Japan) at 40°C and a refractive index detector 
(RI-101; Showa Denko), using chloroform as the eluent at a flow rate of 0.5 ml/min (Miki 
et al., 2010). Narrowly distributed poly(styrenes) (Showa Denko) were used as the MW 
standards. 
 
2.3.2. Measurement by using 1H-NMR 
1H-NMR spectroscopy was used to determine the composition of the synthetic 
polymer A (JNM-ECA600; JEOL Ltd., Tokyo, Japan); deuterated chloroform (CDCl3; 
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99.96% D; ISOTEC, Inc., Miamisburg, OH, USA) at room temperature was used as the 
solvent. The sample solution was prepared at a concentration of 4.0 mg/ml (Miki et al., 
2010). 
 
2.3.3. Calculation of polymer composition 
The chemical shifts of the functional groups of the chemicals and of the synthetic 
polymers used in the present study are shown in Table 4. In addition, the values of the 
chemical shifts, except for those of AMBN, were obtained from the literature and were 
used as a reference (Hamurcu et al., 1996; Hesse. et al., 2000; Laverty et al., 1977); 
Mojsiewicz-Pieńkowska et al., 2003; Tamura, 1991). The values of the chemical shifts 
of FM-0711 and of VPE-0601 were consistent with those reported in the literature. The 
chemical shifts at δ -0.1~0.2 (symbol: a) and δ 3.60~3.65 (symbol: f) were selected for 
calculating the mole ratio of each unit in polymer A (Fig. 1 and Table 4). VPE-0601 and 
FM-0711 were converted to PEG 6000 and PDMS units in the calculation of the polymer 
composition (Miki et al., 2010). The mole ratio of each unit was calculated according to 
the signal intensity ratio. Finally, the mole ratios were converted to weight ratios by 
multiplying them by the MW of the components (PDMS units, 724 Da and PEG 6000 
units, 6000 Da; Table 3). 
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 2.4. Preparation of polymer-impregnated membranes for the 2-chamber diffusion cell 
experiment 
The synthetic polymers were dissolved in chloroform to a concentration of 100 
mg/ml. We dropped 200 µl of the polymer solution onto a polyethylene terephthalate 
(PET) film (NF SP-PET 751031; LINTEC Co., Tokyo, Japan) placed on a flat glass plate. 
Then, a sheet of hydrophilized polytetrafluoroethylene (PTFE) membrane filter 
(Omnipore JH; pore size, 0.45 µm; diameter, 25 mm; Nihon Millipore, Tokyo, Japan) was 
overlaid immediately on the polymer solution. The impregnated membrane was kept still 
at ambient temperature for 1 h and then under ordinary pressure at 100°C for 24 h in an 
oven to dry and to ensure complete removal of the solvent. The impregnated membranes 
containing polymer A and polymer B were designated as membrane A and membrane B, 
respectively. 
 
2.5. In vitro permeation study using a 2-chamber diffusion cell 
The physicochemical properties of the model compounds used for the permeation 
study are shown in Tables 1-2. Table 1 contains apparent octanol/water partition 
coefficient (log KO/W). We obtained log KO/W from a previous report (Morimoto et al., 
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1992). The values of KO/W is obtained by calculating the solubility ratio in octanol/water 
at 37°C on a set of experiments (Morimoto et al., 1992). Note that the values of KO/W 
depend on the data source, and often can be different according to the methods (other 
methods e.g. shake flask method) and experimental condition (solvent, their pH and 
temperature and so on). And, even though described as the same method and condition, 
the values of KO/W may not be necessarily the same. The range of MWs for these 
compounds was within a factor of 1.69 (MW, 188 to 318 Da), whereas the KO/W values 
varied over a factor of 108 (log KO/W, -4.70 to 3.86). Thus, the permeability through the 
lipophilic membranes was expected to be influenced predominantly by the KO/W values 
but not by the MW. We defined the lipophilic compounds as those with a log KO/W ≥ 0 and 
the hydrophilic compounds as those with a log KO/W < 0. In the case of membrane B, the 
apparent permeability coefficient (P) (cm/s) was determined only for compounds with a 
log KO/W ≥ -2.0. The cumulative amount of L-DP permeated up to 48 h was less than the 
detection limit (0.05 µg/ml); similarly, the concentration of the two other hydrophilic 
compounds, IPH and DPH, was also less than the detection limit, and thus, their 
concentrations could not be determined. The prepared membranes were mounted in the 
2-chamber diffusion cell (effective diffusion area, 0.95 cm2) (Okumura et al., 1989). The 
donor compartment was filled with 2.6 ml saturated compound solutions in purified water 
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containing an excess of the compounds to maintain the maximal thermodynamic activity. 
For ANP, IPH, and DPH, the donor concentrations of which were 100 mg/ml in purified 
water, the receiver compartment was filled with 2.6 ml purified water. In the case of FP 
and KP, maintaining sink condition was difficult because these compounds were highly 
lipophilic. Therefore, we used an aqueous solution of 40% PEG 400 as the receiver 
solution to increase the solubility of these two lipophilic compounds (Yamaguchi et al., 
1997). The donor and receiver phases were stirred using magnetic stirrers and kept at 
37°C by circulating warm water in the water jackets of the chambers. A suitable volume 
of the receiver solution was removed at predetermined times and then the same volume of 
fresh purified water or the aqueous solution of 40% PEG 400 was added to the receiver 
compartment to maintain constant volume. The concentrations of the compounds in the 
receiver solution were assayed to determine the cumulative amount of the compounds 
permeated at each sampling time point. The cumulative amounts were plotted against 
time, and the steady-state flux (J, rate of compound permeated per unit area) was derived 
from the linear part of the profiles. P values were calculated by dividing J by the 
solubility of each compound for the suspended solution or the specified concentration: 
100 mg/ml for ANP, IPH, and DPH. The sink condition ensured that concentration of the 
compound in the receiver phase was less than 10% of the concentration of the compound 
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in the donor phase. 
 
2.6. Preparation of the PAMPA model for polymer A 
Polymer A was dissolved in chloroform to a concentration of 100 mg/ml. We 
dropped 17 µl of the polymer solution onto a hydrophobic polyvinylidene difluoride 
(PVDF) membrane place in a 96-well plate (MultiScreen IP filter plate; pore size, 0.45 
µm; Nihon Millipore). The upper plates were kept still at ambient temperature for at least 
12 h to completely evaporate the solvent. 
 
2.7. In vitro permeation study using the PAMPA model 
Permeation experiments were performed using the polymer A-impregnated 96-well 
plate. The donor plate was filled with 280 µl of the compound in purified water, 
citrate-phosphate buffer, or phosphate buffer. For ISDN and NR, purified water was used 
as the donor solvent. Donor solvents for other compounds were citrate-phosphate buffer 
or phosphate buffer adjusted at a pH value corresponding to that of the aqueous 
suspension of the compound (Table 2) (Morimoto et al., 1992). The donor concentrations 
of tested compounds were set at 20% of the saturated solubility of each compound (Table 
1). The receiver plate was filled with 280 µl purified water. For KP, an aqueous solution 
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of 40% PEG 400 was used as the receiver solution. A donor plate mounted on a receiver 
plate (MultiScreen IP filter plate; pore size, 0.45 µm; Nihon Millipore) was incubated at 
37°C for predetermined time. Permeation periods were for KP, LC, ISDN, AMP, DC-Na 
and NR were 2.5, 2.5, 0.5, 1.0, 5.0 and 5.0 h, respectively. After the specified permeation 
periods, the donor and receiver plate were separated, and then, a suitable volume of 
receiver solution was immediately removed and assayed. For experiments performed 
using the 96-well plate, apparent J (JPAMPA) was obtained by dividing the amount of 
compounds permeated from the start time to that at the end of the permeation period by 
the permeation period; the assumed permeation profiles were almost linear. Apparent P 
(PPAMPA) values were calculated by dividing the apparent J by the initial donor 
concentration. The sink condition ensured that the concentration of the compound in the 
receiver phase was less than 10% of the concentration of the compound in the donor 
phase.  
 
2.8. Analytical methods 
The concentrations of the compound in the receiver phase were determined using an 
ultraviolet (UV) spectrophotometer with a microplate reader (SpectraMax M2e; 
Molecular Devices, Sunnyvale, CA, USA). The sample solution or reference solution was 
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placed in each well of the 96-well UV-transparent microplate (BD Falcon, NJ, USA) or 
UV-star Half Area microplate (Greiner Bio-one, Tokyo, Japan). The UV detection 
wavelengths are shown in Table 1 (Hatanaka et al., 1990). An HPLC system was used to 
determine the concentration of L-DP obtained using the 2-chamber diffusion cell (Miki et 
al., 2010), and the HPLC conditions were similar to those reported previously (Hatanaka 
et al., 1990) for performing detection with a high sensitivity.  
 
2.9. Statistical analysis  
Correlation analysis was used to examine the relationships between log KO/W values 
of the compounds and the logarithm of the P through the membranes A and B. In addition, 
correlation analysis was used to examine the relationships between the logarithm of the P 
through each impregnated membrane and through human skin obtained from both 
permeation studies using a 2-chamber diffusion cell and a 96-well plate. A level of p < 
0.05 was considered significant. 
 
3. Results and Discussion  
 
In this study, we synthesized two polymers (polymers A and B), one containing 
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PDMS and PEG 6000 units and the other without PEG 6000 units. The polymers were 
used to prepare membrane A with PEG units and membrane B without PEG units.  
3.1. Evaluation of synthetic polymers 
The unit composition of PDMS and PEG 6000 might be a crucial factor for 
determining the properties of the polymer. Thus, we evaluated the properties of the 
polymers using GPC and 1H-NMR. The feed ratio, estimated composition of PDMS and 
PEG units, and average MW of the polymers are shown in Table 3. The Mn of polymers A 
and B was 157 and 52 kDa, and the Mw was 209 and 106 kDa, respectively. The 
estimated unit content of polymer A was 96.5 wt% for PDMS units and 3.5 wt% for PEG 
6000 units, which reflected the feed ratio of FM-0711 and VPE-0601. This trend was 
consistent with that observed in our previous study performed using VPE-0601 (Miki et 
al., 2010).  
 
3.2. An in vitro permeation study using the 2-chamber diffusion cell 
 
3.2.1. Permeation behaviours of the compounds through the impregnated membranes 
We performed permeation studies using a 2-chamber diffusion cell and evaluated the 
permeation behaviours of the compounds through membranes A and B. The cumulative 
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amounts of ISDN and NR that permeated across membranes A and B are shown in Fig. 2 
as typical permeation profiles. The values of J, P, and lag time of the compounds through 
the impregnated membranes are shown in Table 5. We used L-DP, a highly hydrophilic 
compound, and confirmed that membrane B cannot be used for appropriate evaluation of 
the permeation behaviour of hydrophilic compounds. No permeation of L-DP through 
membrane B was detected until 48 h (the concentration of L-DP in the receiver phase was 
below the detection limit of 0.05 µg/ml, and the P value of L-DP through membrane B 
was below 1.58 × 10-10 cm/s). This finding confirmed that membrane B was a highly 
lipophilic barrier without any hydrophilic region or pores. The value of log P through the 
human skin (log Phum.) (Morimoto et al., 1992) and through the impregnated membranes 
A and B (log Pmem. A and log Pmem. B, respectively) were used for the various analyses 
detailed below (Table 6). The relationship between log KO/W and log Pmem. is shown in Fig. 
3. The values of log Pmem. B and log Pmem. A were dependent on the KO/W for the compounds 
with a log KO/W ≥ -2.0 (Fig. 3). In contrast, the values of log Pmem. A for the compounds 
with a log KO/W < -2.0 were constant at -6.717 to -6.438 (Fig. 3b). The regression lines 
obtained for the compounds with log KO/W ≥ -2.0 (solid line in each panel) are shown in 
Eq. 1 and 2. 
log Pmem. B = 0.698 log KO/W − 5.961                                                       (Eq. 1) 
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(Fig. 3a, determination coefficient (R2) = 0.859, p < 0.05, n = 9)  
log Pmem. A = 0.520 log KO/W − 5.272                                                        (Eq. 2) 
(Fig. 3b, R2 = 0.843, p < 0.05, n = 9) 
The slopes and R2 values of the regression lines were similar to each other (Eq. 1 and 
2). We used a physicochemical approach to differentiate between the compounds with log 
KO/W ≥ -2.0 and the compounds with log KO/W < -2.0. The lipophilic compounds might 
permeate through a lipophilic region in the skin or polymer membranes depending on 
their KO/W values. However, the permeation of highly hydrophilic compounds with log 
KO/W < -2.0 across such lipophilic regions may be difficult because these regions would 
act as a potent barrier. These hydrophilic compounds permeate easily through the 
hydrophilic regions in the skin or polymer membranes, which are regarded as water-filled 
pores (Hatanaka et al., 1990). When the MW of the compounds does not vary, their 
permeation through hydrophilic pathways is assumed to be almost constant and to be 
independent of their KO/W values. The values of log Pmem. B and log Pmem. A increased with 
an increase in the KO/W values for the lipophilic compounds, and the slopes and R2 values 
of the regression lines were similar (Fig. 3 and Eq. 1 and 2). These results indicated that 
both membranes A and B had lipophilic regions with similar properties. This might be 
related to the fact that membranes A and B contained a high amount of PDMS units 
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(Table 3). Thus, the permeability of these membranes was thought to be dependent on the 
indicators of the polarity of the compounds, such as their KO/W values (Geinoz et al., 
2002; Hatanaka et al., 1990). 
The log Pmem. A values of the compounds with a log KO/W < -2.0 were almost constant 
(log Pmem. A: -6.72 to -6.44 cm/s). Further, we observed a trend for hydrophilic compounds 
similar to that observed in our previous studies on human and hairless rat skin (Morimoto 
et al., 1992). This trend is thought to originate from the presence of a small proportion of 
hydrophilic regions in the skin. In our previous study, we synthesized MMA/GMA/PEG 
6000 copolymers and noted the possibility that PEG 6000 units formed a hydrophilic 
microdomain in the copolymer membranes (Miki et al., 2010). Therefore, a hydrophilic 
region that consists of PEG 6000 units is considered to exist separately from the lipophilic 
region in membrane A, which indicates that membrane A has a microphase-separated 
structure.  
 
3.2.2. Correlative evaluation between the permeability of the impregnated membranes 
and the human skin 
The R2 and slope values in the regression analysis of the log Pmem.–log Phum. 
correlation were used as indicators for evaluating alternatives to the human skin. The 
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relationships between the log Pmem. B and log Phum. for the lipophilic compounds is shown 
in Fig. 4a, and the relationship between the log Pmem. A and log Phum. for the lipophilic and 
hydrophilic compounds is shown in Fig. 4b. The regression lines obtained are shown in 
Eq. 3 and 4. 
log Phum. = 0.846 log Pmem. B - 1.544                                                        (Eq. 3) 
(Fig. 4a; R2 = 0.913, p < 0.05, n = 9)  
log Phum. = 1.067 log Pmem. A - 0.899                                                        (Eq. 4) 
(Fig. 4b; R2 = 0.930, p < 0.05, n = 12)  
Eq. 3 and 4 indicated good linear relationships; the R2 values were 0.913 and 0.930, 
and the slopes were 0.846 and 1.067, respectively. Although good correlation was 
observed between log Pmem. B and log Phum. for the compounds with a log KO/W ≥ -2.0 (Fig. 
4a and Eq. 3), we could not determine the permeability of membrane B for L-DP. 
Therefore, these results confirmed that the membrane composed of PDMS units alone 
cannot be used to predict accurately the permeability of the human skin for highly 
hydrophilic compounds with log KO/W < -2.0. A good correlation was observed between 
log Pmem. A and log Phum. not only for the lipophilic but also for the hydrophilic compounds, 
and the slope of the regression line was close to 1.0, which is the ideal value (Fig. 4b and 
Eq. 4).  
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 3.3. Correlative evaluation between the permeability obtained using the PAMPA model 
and that of the human skin 
As mentioned above, the presence of a microdomain, which consists of PEG 6000 
units, in membrane A works as a permeation pathway for compounds with a log KO/W < 
-2.0. In addition, a good relationship was observed between the log Pmem. A and log Phum. 
values for lipophilic and hydrophilic compounds. Because polymer A would be a good 
candidate for preliminary evaluation of the human skin permeability for lipophilic and 
hydrophilic compounds, we used polymer A as the PAMPA model for development of a 
HTS system. Further, we performed permeation studies using the PAMPA model of 
polymer A and evaluated the permeation behaviours of the compounds. The values of 
JPAMPA, PPAMPA, and log PPAMPA of the compounds permeated through the PAMPA model 
are shown in Tables 7-8. We determined the concentrations of the six compounds in the 
receiver phase by using a microplate reader. Further, we evaluated the PPAMPA values of six 
compounds over a permeation period of 0.5–5.0 h. Thus, the use of polymer A in the 
PAMPA enabled rapid and easy evaluation of the permeability of the compounds. The 
relationship between the log PPAMPA and log Phum. values for the six compounds is shown 
in Fig. 5. The regression line obtained is shown in Eq. 5. 
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log Phum. = 1.046 log PPAMPA – 0.360                                                        (Eq. 5) 
(Fig. 5; R2 = 0.927, p < 0.05, n = 6)  
We obtained a good linear relationship; the R2 value was 0.927, and the slope was 
1.046, respectively. An ideal correlation between log PPAMPA and log Phum. was obtained  
including NR, which is relatively hydrophilic (log KO/W; -1.02; Table 1, Fig. 5 and Eq. 5). 
This result suggested that PEG 6000 units in polymer A worked as a hydrophilic region 
similar to that observed using the 2-chamber diffusion cell. The PAMPA model using 
polymer A enabled rapid and easy prediction of the permeability of the human skin not 
only for lipophilic compounds but also for hydrophilic compounds. The SC is a 
heterogeneous membrane, which has several pathways for permeation (Mitragotri, 2003). 
Therefore, the barrier properties of the skin cannot be perfectly mimicked from a 
chemical and biological point of view by artificial materials. However, a physicochemical 
approach to determine the permeation behaviour of the skin indicates that the skin has at 
least two pathways: a lipophilic pathway, which is present to a large extent, and a 
hydrophilic pathway, which is present in a small extent. Ottaviani et al. (2006) reported a 
PAMPA model for skin permeation (PAMPA-skin) that could be easily prepared by 
mixing silicone oil and isopropyl myristate as an impregnated membrane. This model was 
a simple physical mixture, and thus, it had a homogeneous structure. Sinkó et al. (2012) 
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reported another PAMPA-skin that was prepared by using several ceramides, cholesterol, 
stearic acid, and silicone oil. Several studies have reported a solid copolymer membrane 
or composite membrane for use as an alternative to the skin for studies on skin 
permeability; these membranes have lipophilic and hydrophilic pathways (Hatanaka et al., 
1992; Miki et al., 2010; Yamaguchi et al., 1997). However, since these were solid 
membranes, application of these polymers to a 96-well plate would be difficult. Polymer 
A synthesized in our study was a liquid rubber. These polymers had a single-stranded 
structure and consisted of a large part of a silicone component, which had a low 
glass-transition point (typically -125 to -127°C) (Morishita et al., 2009; Rutnakornpituk 
et al., 2005). Although polymer A contained PEG 6000 units having a crystalline 
structure at ambient temperature (Zheng et al., 2005), the content of the PEG 6000 units 
was only 3.5 wt% (Table 3). This structure, composition, and thermal property resulted in 
a liquid rubber polymer at ambient temperature. This liquid rubber property was suitable 
for application on a PAMPA model. In addition, our model has several practical 
advantages, in that it is easy to prepare and to handle in any laboratory and that it is 
physically and chemically more stable than the lipid components. Moreover, this polymer 
is more cost-effective than the three-dimensional cultured human skin model (Schreiber 
et al., 2005) and the artificial lipid membrane (De Jager et al., 2006).  
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 4. Conclusions 
 
Our aim was to develop a HTS system for predicting the permeability of human skin 
by using synthesized polymers with permeation characteristics for lipophilic and 
hydrophilic compounds similar to those of the human skin. Our findings were as follows: 
1) The presence of a microdomain, which consists of PEG 6000 
units, in membrane A works as a permeation pathway for hydrophilic 
compounds.  
2) The 2-chamber diffusion cell study showed a good relationship 
between the permeability of membrane A and that of human skin, not only 
for lipophilic compounds but also for hydrophilic compounds. 
3) The relationship between the permeability of the PAMPA 
model of polymer A and that of human skin is good for both lipophilic and 
hydrophilic compounds. 
 Polymer A can be used to predict the permeability of the human skin for lipophilic 
and hydrophilic compounds. Moreover, the PAMPA model using polymer A can enable 
rapid and easy prediction of the permeability of the human skin. Thus, the PAMPA model 
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using polymer A seems to be a good membrane model for preliminary evaluations of the 
permeability of human skin.  
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Figures and Tables 
Figure captions 
Fig. 1.  Scheme of polymer synthesis. 
The superscript symbols represent the functional group whose chemical shifts are shown 
in Table 4. The molecular weights of the poly(dimethylsiloxane) (PDMS) units, 
poly(ethylene glycol) (PEG) 6000 units, and 
poly(polyoxyethylene-azobiscyanopentanoate) (VPE-0601) were approximately 724 Da, 
6 and 50 kDa, respectively. x = 8, m = 136, and n = 8. 
 
Fig. 2.  The cumulative amounts of isosorbide dinitrate (ISDN) and nicorandil (NR) 
diffused across the impregnated membranes in 2-chamber diffusion cells. 
The data represent the mean ± standard deviation (S.D.) (n = 4).  
 
Fig. 3.  The relationships between the octanol/water partition coefficients (log KO/W) of 
the compounds, and their ability to permeate through the impregnated membranes in 
2-chamber diffusion cells (log Pmem.). 
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Fig. 4.  The relationships between the ability of the compounds to permeate through the 
impregnated membranes (log Pmem.) and through the human skin (log Phum.) in 2-chamber 
diffusion cells. 
*The data were obtained from a previous study (Morimoto et al., 1992). 
 
Fig. 5.  The relationships between the ability of the compounds to permeate through the 
parallel artificial membrane permeation assay (PAMPA) model of polymer A (log PPAMPA) 
and through the human skin. 
*The data were obtained from a previous study (Morimoto et al., 1992). 
KP, ketoprofen; LC, lidocaine; ISDN, isosorbide dinitrate; DC-Na, diclofenac sodium; 
AMP, aminopyrine; NR, nicorandil.  
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Tables 
Table 1. The physicochemical properties of the compounds tested using 2-chamber 
diffusion cells. 
       
 Compound MW (Da) 
Solubility in 
water (mg/ml)a log KO/W
b UV Detection (nm) 
 
  
 Flurbiprofen 244 0.0277 3.86 245  
 Ketoprofen 254 0.185 3.11 254  
 Lidocaine 234 3.03 2.34 245  
 Isosorbide dinitrate 236 1.34 1.34 220  
 Cyclobarbital 236 3.07 0.873 205  
 Aminopyrine 231 55.9 0.497 254  
 Diclofenac sodium 318 32.0 -0.962 286  
 Nicorandil 211 39.6 -1.02 254  
 Antipyrine 188 816 -1.55 245  
 Isoproterenol hydrochloride 247 345 -2.69 280  
 Dopamine hydrochloride 189 520 -3.40 280  
 L-Dihydroxyphenylalanine 197 5.00 -4.70 280  
       
aSolubility in water at 37°C (Morimoto et al., 1992). 
bLogarithm of the octanol/water partition coefficient (log KO/W) at 37°C from a previous 
study (Morimoto et al., 1992). 
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Table 2. The pH of aqueous suspension and the pKa of the compounds tested.  
  pHa pKaa 
Flurbiprofen 4.70  3.73     
Ketoprofen 3.72 3.90      
Lidocaine 6.82 7.86     
Cyclobarbital 3.58 7.50     
Aminopyrine 7.94 5.00     
Diclofenac sodium 7.96 4.00     
Antipyrine 7.60  1.50     
Isoproterenol hydrochloride 2.75 8.57  10.1 12.0   
Dopamine hydrochloride 3.26 8.74  10.3   
L-Dihydroxyphenylalanine 5.42 2.31  8.71 9.74 13.4 
aFrom a previous study (Morimoto et al., 1992). 
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Table 3. The feed ratio, composition, and average molecular weight of the polymers 
synthesized. 
aThe weight ratios in polymer A were calculated using proton nuclear magnetic resonance 
(1H-NMR). 
bWe assumed that the synthesized polymer B consisted only of poly(dimethylsiloxane) 
(PDMS) units. 
cThe average molecular weight (MW) was determined using gel permeation 
chromatography (GPC) calibrated with poly(styrene) standards. 
 
  
   
 
 
Code 
 
 
Feed ratio (wt%) 
  Product  
  
Composition  
(wt%)  
Molecular weight 
distributionc  
 FM-0711 AMBN VPE-0601   PDMS 
PEG 
6000   
Mn 
(kDa) 
Mw 
(kDa) Mw/Mn   
 A 97.00 0  3.00   96.5
a 3.5a  157  209  1.32   
 B 99.69  0.31  0    100
b 0b   52  106  2.03   
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 Table 4. Assignment of the resonance signals of the recorded proton nuclear magnetic 
resonance (1H-NMR) spectra. 
 *Symbols are shown as superscript in Fig. 1. 
  
         
   
Chemical shift 
(δ), ppm Symbol
* 
Literature data 
Chemical shift (δ), ppm 
 FM-0711 −0.1 to 0.2 a 
0.072 (Hamurcu et al., 1996), 0.0~0.5 
(Mojsiewicz-Pieńkowska et al., 2003) 
  1.90~1.95  b 1.97 (Hesse et al., 2000) 
   5.5, 6.1 c 
5.45 (Tamura, 1991), 5.72 (Hesse et al., 2000), 
6.14 (Tamura, 1991), 6.30 (Hesse et al., 2000) 
 VPE-0601 1.6~1.7 d 
1.65 (Laverty et al., 1977), 1.62~1.67 (Hamurcu 
et al., 1996) 
  2.3~2.7 e 
2.45 (Laverty et al., 1977), 2.33~2.68 (Hamurcu 
et al., 1996) 
   3.2~4.0 f 
3.58 (Hesse et al., 2000), 3.60 (Laverty et al., 
1977) 
 AMBN 0.98~1.04  g — 
  1.66~1.68 h — 
   2.0~2.2  i — 
 Polymer A −0.1~0.2 a — 
   3.60~3.65 f — 
 Polymer B −0.1~0.2 a — 
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Table 5. The permeation parameters of the compounds permeated through the 
impregnated membranes in 2-chamber diffusion cells. 
(a) Membrane A                 
Compound J (µg/cm2/h)   P (cm/s)   Lag  time (h)   n 
FP 46.37  ± 5.626   4.65 × 10
−4 ± 0.56 × 10−4  0.02   4  
KP 67.70  ± 6.066   1.02 × 10
−4 ± 0.09 × 10−4  0.11   4  
LC 3238  ± 315.5   2.97 × 10
−4 ± 0.29 × 10−4  0.01   3  
ISDN 606.3  ± 62.05   1.26 × 10
−4 ± 0.13 × 10−4  0.05   4  
CB 33.40  ± 1.895   3.02 × 10
−6 ± 0.17 × 10−6  0.11   4  
AMP 1411  ± 380.0   7.01 × 10
−6 ± 1.89 × 10−6  0.09   4  
DC-Na 113.4  ± 30.75   9.84 × 10
−7 ± 2.67 × 10−7  0.45   4  
NR 262.9  ± 29.94   1.84 × 10
−6 ± 0.21 × 10−6  0.16   4  
ANP 482.3  ± 178.8   1.34 × 10
−6 ± 0.50 × 10−6  0.08   4  
IPH 116.9  ± 74.00   3.25 × 10
−7 ± 2.06 × 10−7  0.54   3  
DPH 69.04  ± 29.64   1.92 × 10
−7 ± 0.82 × 10−7  0.54   4  
L-DP 6.559  ± 3.242    3.64 × 10−7 ± 1.80 × 10−7   0.79    3  
             
(b) Membrane B                 
Compound J (µg/cm2/h)   P (cm/s)   Lag  time (h)   n 
FP 36.63  ± 6.133   3.67 × 10
−4 ± 0.62 × 10−4  0.14   4  
KP 42.37  ± 9.198   6.36 × 10
−5 ± 1.38 × 10−5  0.21   4  
LC 2251  ± 139.7   2.06 × 10
−4 ± 0.13 × 10−4  0.02   3  
ISDN 386.2  ± 37.92   8.01 × 10
−5 ± 0.79 × 10−5  0.03   4  
CB 9.420  ± 1.654   8.52 × 10
−7 ± 1.50 × 10−7  0.19   4  
AMP 319.4  ± 45.35   1.59 × 10
−6 ± 0.23 × 10−6  0.01   4  
DC-Na 8.960  ± 0.8724   7.78 × 10
−8 ± 0.76 × 10−8  1.00   3  
NR 36.92  ± 5.796   2.59 × 10
−7 ± 0.41 × 10−7  0.48   4  
ANP 65.45  ± 7.921   1.82 × 10
−7 ± 0.22 × 10−7  0.23   4  
IPH — 
 
—  —  
—  —  — 
DPH — 
 
—  —  
—  —  — 
L-DP —a   —   —a   —   —   3  
aThe concentration of the receiver phase was below the detection limit of 0.05 µg/ml until 
48 h, which suggested that the P of L-dihydroxyphenylalanine (L-DP) through membrane 
B was below 1.58 × 10-10 cm/s. FP, flurbiprofen; KP, ketoprofen; LC, lidocaine; ISDN, 
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isosorbide dinitrate; CB, cyclobarbital; AMP, aminopyrine; DC-Na, diclofenac sodium; 
NR, nicorandil; ANP, antipyrine; IPH, isoproterenol hydrochloride; DPH, dopamine 
hydrochloride; L-DP, L-dihydroxyphenylalanine. 
 
  
44 
 
Table 6. Permeability through the human skin and impregnated membranes in 2-chamber 
diffusion cells. 
aThe data were obtained from a previous study (Morimoto et al., 1992). 
bThe concentration of the receiver phase was below the detection limit of 0.05 µg/ml until 
48 h. 
 
  
            
 
Compound 
Human skin  Membrane A Membrane B  
 
log Phum. 
 (cm/s)a   
log Pmem. A  
(cm/s) 
log Pmem. B  
(cm/s)  
 Flurbiprofen −3.928   −3.333  −3.435   
 Ketoprofen −4.967   −3.993  −4.196   
 Lidocaine −5.154   −3.527  −3.685   
 Isosorbide dinitrate −5.213   −3.901  −4.097   
 Cyclobarbital −6.355   −5.520  −6.069   
 Aminopyrine −6.510   −5.154  −5.799   
 Diclofenac sodium −7.127   −6.007  −7.109  
 Nicorandil −7.295   −5.734  −6.587   
 Antipyrine −7.733   −5.873  −6.740   
 
Isoproterenol 
hydrochloride −8.021   −6.488  —  
 Dopamine hydrochloride −7.695   −6.717  —  
 L-Dihydroxyphenylalanine −7.662    −6.438  — 
b  
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Table 7. The permeation parameters of compounds permeated through the parallel 
artificial membrane permeability assay (PAMPA) model of polymer A. 
 
 
 
  
             
Compound JPAMPA (µg/cm2/h)   PPAMPA (cm/s)   n 
Ketoprofen 0.6407  ± 0.02877   4.81E-06 ± 2.16E-07  4  Lidocaine 5.381  ± 1.504   2.47E-06 ± 6.89E-07  4  
Isosorbide 
dinitrate 9.146  ± 2.769   9.48E-06 ± 2.87E-06  4  
Aminopyrine 21.36  ± 3.029   5.31E-07 ± 7.53E-08  4  
Diclofenac 
sodium 1.151  ± 0.1489   5.00E-08 ± 6.46E-09  4  
Nicorandil 1.700  ± 0.4431    5.96E-08 ± 1.55E-08   4  
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Table 8. Permeability through the human skin and the parallel artificial membrane 
permeability assay (PAMPA) model of polymer A. 
 
         
 
Compound 
Human skin  Membrane A  
 
log Phum. 
 (cm/s)a   
log PPAMPA 
(cm/s)  
 KP -4.967   -5.318   
 LC -5.154   -5.608   
 ISDN -5.213   -5.023   
 AMP -6.510   -6.275   
 DC-Na -7.127   -7.301   
 NR -7.295    -7.225   
      
aThe data were obtained from a previous study (Morimoto et al., 1992). 
KP, ketoprofen; LC, lidocaine; ISDN, isosorbide dinitrate; AMP, aminopyrine; DC-Na, 
diclofenac sodium; NR, nicorandil.  
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